Depomed recalls Glumetza 500mg due to traces of chemical TBA
This article was originally published in Scrip
Executive Summary
Depomed is voluntarily recalling from wholesalers 52 lots of its diabetes drug Glumetza 500mg (metformin HCl) ER tablets after finding trace amounts of 2,4,6-tribromoanisole (TBA) in bottles – the same chemical that was linked to a recall from Johnson & Johnson's McNeil unit late last year. Santarus, Depomed's promotional partner, plans to focus its promotional efforts on Glumetza 1,000mg until the supply of Glumetza 500mg is resumed; the recall does not impact the 1,000mg formulation.